Volgen
Nan van Geloven
Nan van Geloven
Assistant professor biostatistics, Leiden University medical center
Geverifieerd e-mailadres voor lumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, MBW Spanier, ...
Hepatology 58 (6), 2045-2055, 2013
6432013
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ...
The Lancet Neurology 17 (1), 35-46, 2018
2652018
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis
K Boonstra, EL Culver, LM de Buy Wenniger, MJ van Heerde, ...
Hepatology 59 (5), 1954-1963, 2014
1902014
Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: Disease penetrance and expression in cardiac ryanodine receptor mutation–carrying relatives
C van der Werf, I Nederend, N Hofman, N van Geloven, C Ebink, ...
Circulation: Arrhythmia and Electrophysiology 5 (4), 748-756, 2012
1772012
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data
SM Zinkstok, MDI Vergouwen, ST Engelter, PA Lyrer, LH Bonati, M Arnold, ...
Stroke 42 (9), 2515-2520, 2011
1772011
Oil-based or water-based contrast for hysterosalpingography in infertile women
K Dreyer, J Van Rijswijk, V Mijatovic, M Goddijn, HR Verhoeve, ...
New England Journal of Medicine 376 (21), 2043-2052, 2017
1752017
Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome: a study of electrocardiograms …
PG Postema, PFHM van Dessel, JA Kors, AC Linnenbank, G van Herpen, ...
Journal of the American College of Cardiology 55 (8), 789-797, 2010
1752010
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a …
MAM Beijk, M Klomp, NJW Verouden, N van Geloven, KT Koch, ...
European heart journal 31 (9), 1055-1064, 2010
1462010
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment …
P Damman, MAM Beijk, WJ Kuijt, NJW Verouden, N van Geloven, ...
Journal of the American College of Cardiology 57 (1), 29-36, 2011
1302011
The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI …
WJ Kikkert, N van Geloven, MH van der Laan, MM Vis, J Baan, KT Koch, ...
Journal of the American College of Cardiology 63 (18), 1866-1875, 2014
1232014
Neurocognitive deficits in children with sickle cell disease: a comprehensive profile
CT Hijmans, K Fijnvandraat, MA Grootenhuis, N van Geloven, H Heijboer, ...
Pediatric blood & cancer 56 (5), 783-788, 2011
1202011
Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi
T Israëls, MD van de Wetering, P Hesseling, N van Geloven, HN Caron, ...
Pediatric blood & cancer 53 (1), 47-52, 2009
1172009
Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis
KA Broeze, BC Opmeer, N Van Geloven, S Coppus, JA Collins, ...
Human reproduction update 17 (3), 293-300, 2011
1132011
Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease
B Post, D Muslimovic, N van Geloven, JD Speelman, B Schmand, ...
Movement Disorders 26 (3), 449-456, 2011
1062011
Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD
DC Velseboer, M Broeders, B Post, N van Geloven, JD Speelman, ...
Neurology 80 (7), 627-633, 2013
1032013
Prediction meets causal inference: the role of treatment in clinical prediction models
N van Geloven, SA Swanson, CL Ramspek, K Luijken, M van Diepen, ...
European journal of epidemiology 35, 619-630, 2020
812020
Aspirin in Alzheimer’s disease: increased risk of intracerebral hemorrhage: cause for concern?
H Thoonsen, E Richard, P Bentham, R Gray, N van Geloven, RJ De Haan, ...
Stroke 41 (11), 2690-2692, 2010
802010
Physiological-based cord clamping in very preterm infants—Randomised controlled trial on effectiveness of stabilisation
R Knol, E Brouwer, T van den Akker, P DeKoninck, N van Geloven, ...
Resuscitation 147, 26-33, 2020
722020
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
PF van der Meer, PF Ypma, N van Geloven, JA van Hilten, ...
Blood, The Journal of the American Society of Hematology 132 (2), 223-231, 2018
692018
Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice–the ECSTATIC study: a cluster randomised non …
CH Luymes, RKE Poortvliet, N van Geloven, MWM de Waal, YM Drewes, ...
BMC medicine 16, 1-14, 2018
662018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20